Big Vision
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Big Vision - overview
Established
2015
Location
Suzhou, Jiangsu, China
Primary Industry
Healthcare
About
Based in Suzhou, China and founded in 2015, Suzhou Big Vision Medical Technology Co. , Ltd. , trading as Big Vision, is a medical technology company that focuses on the research and development of ophthalmic disease diagnosis and analysis system. In June 2026, Big Vision raised a Series B+ funding from Lanwan Venture Capital.
The company engages in the research and development of ophthalmic disease diagnosis and analysis systems. Based on an ophthalmic AI-assisted diagnostic system, it uses AI-integrated ophthalmic OCT hardware as its market entry point to provide intelligent system solutions for eye health medical and service units such as primary hospitals, physical examination centers, and optometry centers. It also provides comprehensive one-stop eye health management services for individual users, focusing on eye health data centered on imaging. The company generates revenue by providing comprehensive one-stop eye health management services and selling its proprietary artificial intelligence-assisted diagnostic systems and OCT hardware devices.
Current Investors
Xiangshi Capital, SND Ventures Group, Agriculture Development Innovation Capital
Primary Industry
Healthcare
Sub Industries
Healthcare, Diagnostic Equipment, Medical Devices & Equipment
Website
www.bigvisiontech.com
Verticals
Artificial Intelligence, Manufacturing
Company Stage
Series B
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.